RxDoctor Payments Data

Sandra Lee, DO

Family Medicine · Philadelphia, PANPI 1871955575

Payments from drug & device makers

$1,435in general payments, 2019–2025

Across 88 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$319
  • AbbVie$286
  • Lilly USA, LLC$238
  • GSK$95
  • Pfizer$93
  • Novartis$74
  • plus $330 from 12 others

What the payments were for

  • Food & beverage$1,435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,435 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$55,790
Medicare patients
162
Services billed
490

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide80$120,246
TrulicityDulaglutide23$35,014
JardianceEmpagliflozin33$30,701
JanuviaSitagliptin Phosphate20$24,688
EliquisApixaban19$14,628
FarxigaDapagliflozin Propanediol13$11,173
Dexlansoprazole DrDexlansoprazole13$6,400
Carvedilol ErCarvedilol Phosphate25$4,976
Fluticasone-SalmeterolFluticasone Propion/Salmeterol46$4,224
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,115
Rosuvastatin Calcium251$3,810
Albuterol Sulfate HfaAlbuterol Sulfate105$3,399
Atorvastatin Calcium264$3,131
Novolog FlexpenInsulin Aspart14$2,178
Levothyroxine Sodium151$2,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$319$120,24680 claims
Lilly USA, LLCTrulicity$238$35,01423 claims
Boehringer IngelheimJardiance$42$30,70133 claims
MerckJanuvia$18$24,68820 claims
PfizerEliquis$93$14,62819 claims
AstraZenecaFarxiga$26$11,17313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →